Skip to main content
Erschienen in: Archives of Virology 7/2013

01.07.2013 | Brief Report

HCV infection among cocaine users in the state of Pará, Brazilian Amazon

verfasst von: Aldemir B. Oliveira-Filho, Leila Sawada, Laine C. Pinto, Daiane Locks, Santana L. Bahia, I. Brasil-Costa, José Alexandre R. Lemos

Erschienen in: Archives of Virology | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

In this study, the prevalence, genotype frequency, and risk factors for HCV infection in 384 cocaine users were determined. One hundred twenty-four (32.3 %) cocaine users had anti-HCV antibodies and 120 (31.3 %) had HCV-RNA. Genotyping results indicated the predominance of genotypes 1 (73.3 %) and 3 (26.7 %). Multivariate analysis showed an association of HCV infection with tattoos, shared use of paraphernalia, daily cocaine use, and a long history of cocaine use. The epidemiological aspects of HCV infection among cocaine users presented here should serve as an incentive for the establishment of a program of hepatitis C prevention and control by the local public-health authorities in the Amazon.
Literatur
1.
Zurück zum Zitat Aaron S, McMahon JM, Milano D et al (2008) Intranasal transmission of hepatitis C virus: virological and clinical evidence. Clin Infect Dis 47:931–934PubMedCrossRef Aaron S, McMahon JM, Milano D et al (2008) Intranasal transmission of hepatitis C virus: virological and clinical evidence. Clin Infect Dis 47:931–934PubMedCrossRef
2.
Zurück zum Zitat Aceijas C, Rhodes T (2007) Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 18:352–358PubMedCrossRef Aceijas C, Rhodes T (2007) Global estimates of prevalence of HCV infection among injecting drug users. Int J Drug Policy 18:352–358PubMedCrossRef
3.
Zurück zum Zitat Allison RD, Conry-Cantilena C, Koziol D et al (2012) A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. J Infect Dis 206:654–661PubMedCrossRef Allison RD, Conry-Cantilena C, Koziol D et al (2012) A 25-year study of the clinical and histologic outcomes of hepatitis C virus infection and its modes of transmission in a cohort of initially asymptomatic blood donors. J Infect Dis 206:654–661PubMedCrossRef
4.
Zurück zum Zitat Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436–2441PubMed Alter MJ (2007) Epidemiology of hepatitis C virus infection. World J Gastroenterol 13:2436–2441PubMed
5.
Zurück zum Zitat Amon JJ, Garfein RS, Ahdieh-Grant L et al (2008) Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004. Clin Infect Dis 46:1852–1858PubMedCrossRef Amon JJ, Garfein RS, Ahdieh-Grant L et al (2008) Prevalence of Hepatitis C Virus Infection among Injection Drug Users in the United States, 1994–2004. Clin Infect Dis 46:1852–1858PubMedCrossRef
6.
Zurück zum Zitat Caiaffa WT, Zocratto KF, Osimani ML et al (2010) Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge? Addiction 106:143–151PubMedCrossRef Caiaffa WT, Zocratto KF, Osimani ML et al (2010) Hepatitis C virus among non-injecting cocaine users (NICUs) in South America: can injectors be a bridge? Addiction 106:143–151PubMedCrossRef
7.
Zurück zum Zitat Campiotto S, Pinho JR, Carrilho FJ et al (2005) Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 38:41–49PubMedCrossRef Campiotto S, Pinho JR, Carrilho FJ et al (2005) Geographic distribution of hepatitis C virus genotypes in Brazil. Braz J Med Biol Res 38:41–49PubMedCrossRef
8.
Zurück zum Zitat Campollo O, Roman S, Panduro A et al (2012) Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 123:269–272PubMedCrossRef Campollo O, Roman S, Panduro A et al (2012) Non-injection drug use and hepatitis C among drug treatment clients in west central Mexico. Drug Alcohol Depend 123:269–272PubMedCrossRef
9.
Zurück zum Zitat Carvalho HB, Seibel SD, Burattini MN, Massad E, Reingold A (2003) Hepatitis B and C and syphilis vulnerability related infections among institutionalized disadvantaged youth in São Paulo-Brazil. J Bras Doenças Sex Transm 15:41–45 Carvalho HB, Seibel SD, Burattini MN, Massad E, Reingold A (2003) Hepatitis B and C and syphilis vulnerability related infections among institutionalized disadvantaged youth in São Paulo-Brazil. J Bras Doenças Sex Transm 15:41–45
10.
Zurück zum Zitat Fischer B, Powis J, Firestone Cruz M (2008) Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol 20:29–32PubMedCrossRef Fischer B, Powis J, Firestone Cruz M (2008) Hepatitis C virus transmission among oral crack users: viral detection on crack paraphernalia. Eur J Gastroenterol Hepatol 20:29–32PubMedCrossRef
11.
Zurück zum Zitat Galperim B, Cheinquer H, Stein A et al (2004) Intranasal cocaine use does not appear to be an independent risk factor for HCV infection. Addiction 99:973–977PubMedCrossRef Galperim B, Cheinquer H, Stein A et al (2004) Intranasal cocaine use does not appear to be an independent risk factor for HCV infection. Addiction 99:973–977PubMedCrossRef
12.
Zurück zum Zitat Gelberg L, Robertson MJ, Arangua L et al (2012) Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles. Public Health Rep 127:407–421PubMed Gelberg L, Robertson MJ, Arangua L et al (2012) Prevalence, distribution, and correlates of hepatitis C virus infection among homeless adults in Los Angeles. Public Health Rep 127:407–421PubMed
13.
Zurück zum Zitat Hermanstyne KA, Bangsberg DR, Hennessey K et al (2012) The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf) 34:330–339CrossRef Hermanstyne KA, Bangsberg DR, Hennessey K et al (2012) The association between use of non-injection drug implements and hepatitis C virus antibody status in homeless and marginally housed persons in San Francisco. J Public Health (Oxf) 34:330–339CrossRef
15.
Zurück zum Zitat Lopes CL, Teles SA, Espírito-Santo MP et al (2009) Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. Rev Saude Publica 43:43–50PubMedCrossRef Lopes CL, Teles SA, Espírito-Santo MP et al (2009) Prevalence, risk factors and genotypes of hepatitis C virus infection among drug users, Central-Western Brazil. Rev Saude Publica 43:43–50PubMedCrossRef
16.
Zurück zum Zitat Macías J, Palacios RB, Claro E et al (2008) High prevalence of hepatitis C virus infection among non-injecting drug users: association with sharing the inhalation implements of crack. Liver Int 28:781–786PubMedCrossRef Macías J, Palacios RB, Claro E et al (2008) High prevalence of hepatitis C virus infection among non-injecting drug users: association with sharing the inhalation implements of crack. Liver Int 28:781–786PubMedCrossRef
17.
Zurück zum Zitat Martinez A, Talal AH (2008) Non-injection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int 28:757–760PubMedCrossRef Martinez A, Talal AH (2008) Non-injection drug use: an under-appreciated risk factor for hepatitis C virus transmission. Liver Int 28:757–760PubMedCrossRef
18.
Zurück zum Zitat Martins T, Narciso-Schiavon JL, Schiavon LL (2011) Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras 57:107–112PubMedCrossRef Martins T, Narciso-Schiavon JL, Schiavon LL (2011) Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras 57:107–112PubMedCrossRef
19.
Zurück zum Zitat McMahon JM, Tortu S (2003) A potential hidden source of hepatitis C infection among non-injecting drug users. J Psychoactive Drugs 35:455–460PubMedCrossRef McMahon JM, Tortu S (2003) A potential hidden source of hepatitis C infection among non-injecting drug users. J Psychoactive Drugs 35:455–460PubMedCrossRef
20.
Zurück zum Zitat McMahon JM, Simm M, Milano D, Clatts M (2004) Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob. doi:10.1186/1476-0711-3-6 PubMed McMahon JM, Simm M, Milano D, Clatts M (2004) Detection of hepatitis C virus in the nasal secretions of an intranasal drug-user. Ann Clin Microbiol Antimicrob. doi:10.​1186/​1476-0711-3-6 PubMed
21.
Zurück zum Zitat Morice Y, Cantaloube JF, Beaucourt S et al (2006) Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296–1303PubMedCrossRef Morice Y, Cantaloube JF, Beaucourt S et al (2006) Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. J Med Virol 78:1296–1303PubMedCrossRef
22.
Zurück zum Zitat Murakami J, Nagata I, Iitsuka T et al (2012) Risk factors for mother-to-child transmission of hepatitis C virus: Maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42:648–657PubMedCrossRef Murakami J, Nagata I, Iitsuka T et al (2012) Risk factors for mother-to-child transmission of hepatitis C virus: Maternal high viral load and fetal exposure in the birth canal. Hepatol Res 42:648–657PubMedCrossRef
23.
Zurück zum Zitat Novais AC, Lopes CL, Reis NR et al (2009) Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 104:892–896PubMedCrossRef Novais AC, Lopes CL, Reis NR et al (2009) Prevalence of hepatitis C virus infection and associated factors among male illicit drug users in Cuiabá, Mato Grosso, Brazil. Mem Inst Oswaldo Cruz 104:892–896PubMedCrossRef
24.
Zurück zum Zitat Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cad Saude Publica 26:837–844PubMedCrossRef Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Likely transmission of hepatitis C virus through sharing of cutting and perforating instruments in blood donors in the State of Pará, Northern Brazil. Cad Saude Publica 26:837–844PubMedCrossRef
25.
Zurück zum Zitat Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Prevalence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern Brazil. Mem Inst Oswaldo Cruz 105:103–106PubMedCrossRef Oliveira-Filho AB, Pimenta AS, Rojas MF et al (2010) Prevalence and genotyping of hepatitis C virus in blood donors in the state of Pará, Northern Brazil. Mem Inst Oswaldo Cruz 105:103–106PubMedCrossRef
26.
Zurück zum Zitat Oliveira-Filho AB, Oliveira EH, Castro JAA, Silva LV, Vallinoto ACR, Lemos JAR (2012) Epidemiological aspects of HCV infection in HIV-infected individuals in Piauí State Northeast Brazil. Arch Virol. doi:10.1007/s00705-012-1435-3 PubMed Oliveira-Filho AB, Oliveira EH, Castro JAA, Silva LV, Vallinoto ACR, Lemos JAR (2012) Epidemiological aspects of HCV infection in HIV-infected individuals in Piauí State Northeast Brazil. Arch Virol. doi:10.​1007/​s00705-012-1435-3 PubMed
27.
Zurück zum Zitat Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:607–616PubMedCrossRef Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:607–616PubMedCrossRef
28.
Zurück zum Zitat Sawada L, Pinheiro AC, Locks D et al (2011) Distribution of hepatitis C virus genotypes among different exposure categories in the State of Pará, Brazilian Amazon. Rev Soc Bras Med Trop 44:8–12PubMedCrossRef Sawada L, Pinheiro AC, Locks D et al (2011) Distribution of hepatitis C virus genotypes among different exposure categories in the State of Pará, Brazilian Amazon. Rev Soc Bras Med Trop 44:8–12PubMedCrossRef
29.
Zurück zum Zitat Scheinmann R, Hagan H, Lelutiu-Weinberger C et al (2007) Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend 89:1–12PubMedCrossRef Scheinmann R, Hagan H, Lelutiu-Weinberger C et al (2007) Non-injection drug use and Hepatitis C Virus: a systematic review. Drug Alcohol Depend 89:1–12PubMedCrossRef
30.
Zurück zum Zitat Segurado AC, Braga P, Etzel A, Cardoso MR (2004) Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS 18:135–143PubMedCrossRef Segurado AC, Braga P, Etzel A, Cardoso MR (2004) Hepatitis C virus coinfection in a cohort of HIV-infected individuals from Santos, Brazil: seroprevalence and associated factors. AIDS Patient Care STDS 18:135–143PubMedCrossRef
31.
Zurück zum Zitat Silva MB, Andrade TM, Silva LK et al (2010) Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil. Mem Inst Oswaldo Cruz 105:299–303PubMedCrossRef Silva MB, Andrade TM, Silva LK et al (2010) Prevalence and genotypes of hepatitis C virus among injecting drug users from Salvador-BA, Brazil. Mem Inst Oswaldo Cruz 105:299–303PubMedCrossRef
32.
Zurück zum Zitat Terrault NA, Dodge JL, Murphy EL et al (2012) Sexual transmission of HCV among monogamous heterosexual couples: the HCV partners study. Hepatology. doi:10.1002/hep.26164 PubMed Terrault NA, Dodge JL, Murphy EL et al (2012) Sexual transmission of HCV among monogamous heterosexual couples: the HCV partners study. Hepatology. doi:10.​1002/​hep.​26164 PubMed
33.
Zurück zum Zitat van den Berg CH, van de Laar TJ, Kok A et al (2009) Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat 16:568–577PubMedCrossRef van den Berg CH, van de Laar TJ, Kok A et al (2009) Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat 16:568–577PubMedCrossRef
34.
Zurück zum Zitat Wang CC, Krantz E, Klarquist J et al (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 196:1474–1482PubMedCrossRef Wang CC, Krantz E, Klarquist J et al (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Infect Dis 196:1474–1482PubMedCrossRef
35.
Zurück zum Zitat Xia X, Luo J, Bai J, Yu R (2008) Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 122:990–1003PubMedCrossRef Xia X, Luo J, Bai J, Yu R (2008) Epidemiology of hepatitis C virus infection among injection drug users in China: systematic review and meta-analysis. Public Health 122:990–1003PubMedCrossRef
Metadaten
Titel
HCV infection among cocaine users in the state of Pará, Brazilian Amazon
verfasst von
Aldemir B. Oliveira-Filho
Leila Sawada
Laine C. Pinto
Daiane Locks
Santana L. Bahia
I. Brasil-Costa
José Alexandre R. Lemos
Publikationsdatum
01.07.2013
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 7/2013
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-013-1627-5

Weitere Artikel der Ausgabe 7/2013

Archives of Virology 7/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.